本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NLS Pharmaceutics Ltd.

1.47
+0.04002.80%
盘后1.470.00000.00%16:45 EDT
成交量:4.74万
成交额:7.06万
市值:172.27万
市盈率:-0.22
高:1.53
开:1.44
低:1.44
收:1.43
数据加载中...
2025/04/15

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/10

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/31

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/28

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/16

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/01/08

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/30

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/19

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/12/11

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/11/25

SEC问询函

Form CORRESP - Correspondence
2024/11/21

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/18

SEC问询函

Form CORRESP - Correspondence
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/06

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/04

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]